CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,953,260
- in 5 filings, $6.0M under 10b5-1 plans
Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-02 | Bylund James Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +8,644 | 8,644 | ||
| 2023-03-02 | Hunt Anthony Chief Executive Officer | Shares withheld for taxes | −6,670 | $176.37 | $1.2M | 165,574 |
| 2023-03-02 | Gebski Christine See Remarks | Shares withheld for taxes | −630 | $174.37 | $110K | 29,193 |
| 2023-02-28 | Hunt Anthony Chief Executive Officer | Shares withheld for taxes | −2,748 | $173.28 | $476K | 172,244 |
| 2023-02-28 | Gebski Christine See Remarks | Shares withheld for taxes | −460 | $173.28 | $80K | 29,823 |
| 2023-02-28 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −358 | $173.28 | $62K | 18,454 |
| 2023-02-28 | Snodgres Jon Chief Financial Officer | Shares withheld for taxes | −521 | $173.28 | $90K | 28,122 |
| 2023-02-28 | Bylund James Chief Operating Officer | Shares withheld for taxes | −594 | $173.44 | $103K | 9,139 |
| 2023-02-28 | Hunt Anthony Chief Executive Officer | Shares withheld for taxes | −3,273 | $173.44 | $568K | 174,992 |
| 2023-02-28 | Snodgres Jon Chief Financial Officer | Shares withheld for taxes | −682 | $173.44 | $118K | 28,643 |
| 2023-02-28 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −458 | $173.44 | $79K | 18,812 |
| 2023-02-28 | Gebski Christine See Remarks | Shares withheld for taxes | −452 | $173.44 | $78K | 30,283 |
| 2023-02-16 | Snodgres Jon Chief Financial Officer | Sale | −5,647 | $200.00 | $1.1M | 29,325 |
| 2023-02-06 | Madaus Martin D Director | Grant or award | +111 | 111 | ||
| 2023-02-06 | Madaus Martin D Director | Grant or award · Stock Option (Right to Buy) | +239 | 239 | ||
| 2023-02-06 | Madaus Martin D Director | Grant or award · Stock Option (Right to Buy) | +1,819 | 1,819 | ||
| 2022-11-11 | Hunt Anthony Chief Executive Officer | Option exercise | +25,000 | $33.87 | $847K | 203,265 |
| 2022-11-11 | Hunt Anthony Chief Executive Officer | Sale | −25,000 | $200.00 | $5.0M | 178,265 |
| 2022-11-11 | Hunt Anthony Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | +25,000 | 34,246 | ||
| 2022-10-07 | Snodgres Jon Chief Financial Officer | Option exercise | +466 | $59.52 | $28K | 34,972 |
Page 17 of 23 · 455 trades